The UAE Diabetes Devices Market is expected to witness growth from $114 Mn in 2022 to $213 Mn in 2030 with a CAGR of 8.20% for the forecasted year 2022-2030. The high prevalence of diabetes, the quick uptake of novel products, increased R&D efforts, and the raising awareness of diabetes preventive care are some major market drivers for diabetes devices in the UAE. The market is segmented by type and by the end user. Some key players in this market include Mecomed, Pioneer Medical Supplies, Johnson & Johnson, Philipps Healthcare, Medtronic, DSM N.V., Roche and Dexcom.
The UAE Diabetes Devices Market size is at around $114 Mn in 2022 and is projected to reach $213 Mn in 2030, exhibiting a CAGR of 8.20% during the forecast period. Healthcare costs in the UAE are present at $2,996.36 per person, up from $2,843.78 in 2018. The UAE's GDP include 5.5% of healthcare spending in 2021. Male and female life expectancy statistics in the UAE are 78.21 and 80.99 years, respectively, in 2022.
Diabetes is predicted to be more common in the UAE than the global norm of 10.5%, at 17.3%. As of 2022, 1.19 million UAE residents, or approximately 18.9% of the population, had diabetes. In UAE, medical advancements such as diabetes devices were developed to help diabetics manage their condition. Blood glucose metres are the tools used to test blood glucose levels. By monitoring their blood sugar levels, diabetics can adjust their lifestyle or medication as needed. A greater quality of life, better glycemic control, and a decreased risk of complications are all benefits. In UAE, the majority of blood glucose metres are available and supported by health insurance. Continuous Glucose Monitoring (CGM), which sends the data to a receiver or smartphone software, continuously monitors blood sugar levels. Advantages include improvements in glycemic control, a lower risk of hypo and hyperglycemia, and an overall increase in quality of life. CGM systems are available in the UAE and backed by health insurance for patients who qualify.
Market Growth Drivers
The high prevalence of diabetes, the quick uptake of novel products, increased R&D efforts, and the raising awareness of diabetes preventive care are some major market drivers for diabetes devices in the UAE. Several diabetes awareness programmes and government initiatives are anticipated to add to market growth during the forecast period. The demand for diabetes screening and monitoring devices is rising as more people become aware of the risks linked to diabetes. This is driving the growth of the diabetes devices market in the UAE. Patients are finding it simpler to monitor their blood glucose levels and control their condition because of advancements in diabetes device technology. Manufacturers are releasing cutting-edge products like smart insulin pens and CGMs, which are assisting with the growth of the UAE diabetes devices market.
Market Restraints
The UAE market for diabetes devices is highly competitive among makers, which frequently results in price rivalry. Manufacturers may find it difficult to make a profit due to the ongoing demand to keep prices low in order to remain competitive. Although diabetes is more widely recognised in the UAE, many patients may not fully understand how to use their devices and manage their condition. This may lower the demand for diabetes devices and make it more difficult for manufacturers to educate users and healthcare professionals.
Key Players
September 2021: Roche announced a partnership with the Abu Dhabi Health Services Company (SEHA) to provide diabetes care and education in Abu Dhabi. As part of the collaboration, patients with diabetes can use Roche's mySugr app to better control their condition and their quality of life.
A regulatory framework for diabetes devices is in place in the well-established healthcare system of the United Arab Emirates. The Ministry of Health and Prevention (MOHAP) is the primary regulatory body for healthcare in the UAE, and it is in charge of creating and carrying out healthcare laws and regulations. The MOHAP is in charge of registering and approving diabetes devices. The UAE's national standardisation body, Emirates Authority for Standardization and Metrology (ESMA), is in charge of creating and enforcing the technical guidelines and standards for diabetes devices. Diabetes device safety and quality requirements are met thanks to ESMA's collaboration with the MOHAP. Healthcare services in Dubai are governed and supervised by the Dubai Health Authority (DHA). The DHA and MOHAP collaborate closely to make sure that diabetes devices adhere to strict safety and quality requirements. The criteria for the registration, approval, and marketing of medical devices in the UAE are outlined in the Medical Device Regulations (MDR). Specific specifications for diabetes devices are included in the MDR, including requirements for performance and safety.
1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Type (Revenue, USD Billion):
The market is divided into blood glucose monitoring systems, insulin delivery systems, and mobile applications for managing diabetes within the type segment. Due to its convenience, ease of use, and usefulness in providing patients and healthcare professionals with real-time insights regarding diabetic conditions for integrated diabetes management, the segment for diabetes management mobile applications is anticipated to grow at the highest rate during the forecast period. Bare-metal Stents
By End User (Revenue, USD Billion):
The diabetes market is divided into hospitals & specialty clinics and self & home care, based on the end user.
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
The market is segmented by type and by the end user.
The UAE Diabetes Devices Market is studied from 2022-2030.
Mecomed, Pioneer Medical Supplies, Johnson & Johnson, Philipps Healthcare, Medtronic, DSM N.V., Roche and Dexcom are the major companies operating in the UAE diabetes devices market.
This report addresses
Need more?